The Latest Breaking News from Cancer

Dr Reddy's gets DCGI nod for Zytorvi in advanced esophageal cancer

Dr Reddy's Laboratories has received approval for Zytorvi, an immunotherapy targeting advanced esophageal squamous cell carcinoma. This new indication allows treatment for adult patients with a combination of toripalimab, cisplatin, and paclitaxel. Approximately 80 percent of esophageal cancer cases in India are attributed to esophageal squamous cell carcinoma. The approval…

The Economic Times · 6h ago

5 Fatty Liver Subtypes Could Change How Doctors Assess Risk

Two people can receive the same fatty liver diagnosis but face very different health risks. One may have a relatively mild condition, while another could be more vulnerable to serious liver damage, heart disease or other complications. Scientists at Mayo Clinic have now identified five biologically distinct subtypes of metabolic…

MyLifeXP · 8h ago

Adults Without a Regular Doctor Had 61% Higher Risk of Being Overdue for Colorectal Cancer Screening

Adults without a usual source of care were far more likely to be overdue for colon cancer screening. Here is how to start at 45, including an at-home stool test.

Medical Daily · 10h ago

One in Four Carboplatin Rationing Decisions at Dana-Farber Did Not Match Its Own Policy During the 2023 Shortage

A Dana-Farber review found that 26% of carboplatin rationing decisions during the 2023 shortage did not match policy. What it means for cancer patients.

Medical Daily · 22h ago

Jemperli Wins Accelerated FDA Approval for a Rectal Cancer Subtype as Most Trial Patients Avoided Surgery

FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should ask.

Medical Daily · Oct 20

Four health checks men should stop putting off in their 40s, 50s and 60s

On average, men in the UK die almost four years earlier than women from largely preventable diseases

The Independent UK · Oct 20

Could Your Face Reveal Your Cancer Survival Odds? AI Study Links Older Appearance to 21% Higher Death Risk

Researchers at Mass General Brigham developed experimental AI tools that use facial photographs to estimate cancer patients' biological age and mortality risk, though clinical trials are still needed.

International Business Times UK · Oct 20

Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results

Merck and Moderna are preparing to seek FDA approval for a personalized mRNA melanoma vaccine used with Keytruda. No filing date has been set.

Medical Daily · Oct 20

6 Facts About Thyroid Nodules to Know Before You Panic at an Ultrasound

Most Thyroid Nodules Are Found by AccidentThyroid nodules are discovered far more often during imaging done for something else entirely, a neck ultrasound ordered for a swollen lymph node, a CT scan for a spine complaint, than they are from symptoms a patient notices. The American Thyroid Association estimates that…

Times Life · Oct 20

You can detect biological age and a person's chance of surviving cancer 'with just one photo'

An AI tool was trained on more than 40 million pictures to determine key indicators of a person's health

The Independent UK · Oct 19